Scattering of a Long Cosmic String by a Rotating Black Hole

The scattering of a straight, infinitely long string by a rotating black hole is considered. We assume that a string is moving with velocity v and that initially the string is parallel to the axis of rotation of the black hole. We demonstrate that as a result of scattering, the string is displaced in the direction perpendicular to the velocity by an amount kappa(v,b), where b is the impact parameter. The late-time solution is represented by a kink and anti-kink, propagating in opposite directions at the speed of light, and leaving behind them the string in a new ``phase''. We present the results of the numerical study of the string scattering and their comparison with the weak-field approximation, valid where the impact parameter is large, b/M >> 1, and also with the scattering by a non-rotating black hole which was studied in earlier works.Comment: 27 pages, 14 figures, to be published in Classical and Quantum Gravit

Highly syntenic and yet divergent: a tale of two Theilerias

The published genomic sequences of the two major host-transforming Theileria species of cattle represent a rich resource of information that has allowed novel bioinformatic and experimental studies into these important apicomplexan parasites. Since their publication in 2005, the genomes of T. annulata and T. parva have been utilised for a diverse range of applications, ranging from candidate antigen discovery to the identification of genetic markers for population analysis. This has led to advancements in the quest for a sub-unit vaccine, while providing a greater understanding of variation among parasite populations in the field. The unique ability of these Theileria species to induce host cell transformation is the subject of considerable scientific interest and the availability of full genomic sequences has provided new insights into this area of research. This article reviews the data underlying published comparative analyses, focussing on the general features of gene expression, the major Tpr/Tar multi-copy gene family and a re-examination of the predicted macroschizont secretome. Codon usage between the Theileria species is reviewed in detail, as this underpins ongoing comparative studies investigating selection at the intra- and inter-species level. The TashAT/TpshAT family of genes, conserved between T. annulata and T. parva, encodes products targeted to the host nucleus and has been implicated in contributing to the transformed bovine phenotype. Species-specific expansion and diversification at this critical locus is discussed with reference to the availability, in the near future, of genomic datasets which are based on non-transforming Theileria species

Instability of a membrane intersecting a black hole

The stability of a Nambu-Goto membrane at the equatorial plane of the Reissner-Nordstr{\o}m-de Sitter spacetime is studied. The covariant perturbation formalism is applied to study the behavior of the perturbation of the membrane. The perturbation equation is solved numerically. It is shown that a membrane intersecting a charged black hole, including extremely charged one, is unstable and that the positive cosmological constant strengthens the instability.Comment: 12 pages, 3 figures, to be published in Physical Review

Thick domain walls around a black hole

We discuss the gravitationally interacting system of a thick domain wall and a black hole. We numerically solve the scalar field equation in the Schwarzschild spacetime and obtain a sequence of static axi-symmetric solutions representing thick domain walls. We find that, for the walls near the horizon, the Nambu--Goto approximation is no longer valid.Comment: 18 pages, 11 figures, one reference adde

Rigidly Rotating Strings in Stationary Spacetimes

In this paper we study the motion of a rigidly rotating Nambu-Goto test string in a stationary axisymmetric background spacetime. As special examples we consider the rigid rotation of strings in flat spacetime, where explicit analytic solutions can be obtained, and in the Kerr spacetime where we find an interesting new family of test string solutions. We present a detailed classification of these solutions in the Kerr background.Comment: 19 pages, Latex, 9 figures, revised for publication in Classical and Quantum Gravit

Thick Domain Walls and Charged Dilaton Black Holes

We study a black hole domain wall system in dilaton gravity which is the low-energy limit of the superstring theory. We solve numerically equations of motion for real self-interacting scalar field and justify the existence of static axisymmetric field configuration representing the thick domain wall in the background of a charged dilaton black hole. It was also confirmed that the extreme dilaton black hole always expelled the domain wall.Comment: 10 pages, 8 figures; to be published in Phys. Rev. D1

Reissner-Nordstrom Black Holes and Thick Domain Walls

We solve numerically equations of motion for real self-interacting scalar fields in the background of Reissner-Nordstrom black hole and obtained a sequence of static axisymmetric solutions representing thick domain walls charged black hole systems. In the case of extremal Reissner-Nordstrom black hole solution we find that there is a parameter depending on the black hole mass and the width of the domain wall which constitutes the upper limit for the expulsion to occur.Comment: 18 pages, 10 figures, accepted for Phys. Rev.

Effect of ospemifene on moderate or severe symptoms of vulvar and vaginal atrophy.

Objectives To determine whether assessment of all moderate-to-severe symptoms at baseline gives a more accurate evaluation of the treatment effect of ospemifene in vulvovaginal atrophy (VVA) than the most bothersome symptom (MBS) approach. Methods Data were pooled from two pivotal phase-III clinical trials evaluating the efficacy and safety of oral ospemifene 60 mg/day for the treatment of symptoms of VVA (n = 1463 subjects). Symptoms of vaginal dryness, dyspareunia, and vaginal and/or vulvar irritation/itching reported as moderate or severe at baseline were evaluated. Clinically relevant differences between ospemifene and placebo were analyzed using a four-point severity scoring system and presented as improvement, substantial improvement, or relief. Results Subjects in these studies reported statistically significant improvement, substantial improvement, and relief for vaginal dryness (p \u3c 0.00001), dyspareunia (p \u3c 0.001) and statistically significant improvement and relief for vaginal and/or vulvar irritation/itching (p \u3c 0.01) from baseline to week 12 with ospemifene compared with placebo. A similar trend was observed for women who reported substantial improvement of vaginal and/or vulvar irritation/itching. Conclusions For drug registration purposes, the use of the MBS model is appealing because of its simplicity and ease of scientific validation. However, the MBS model may underestimate the total magnitude of the clinical benefit of ospemifene treatment for symptomatic women suffering from VVA

Effect of ospemifene on moderate or severe symptoms of vulvar and vaginal atrophy.

Objectives To determine whether assessment of all moderate-to-severe symptoms at baseline gives a more accurate evaluation of the treatment effect of ospemifene in vulvovaginal atrophy (VVA) than the most bothersome symptom (MBS) approach. Methods Data were pooled from two pivotal phase-III clinical trials evaluating the efficacy and safety of oral ospemifene 60 mg/day for the treatment of symptoms of VVA (n = 1463 subjects). Symptoms of vaginal dryness, dyspareunia, and vaginal and/or vulvar irritation/itching reported as moderate or severe at baseline were evaluated. Clinically relevant differences between ospemifene and placebo were analyzed using a four-point severity scoring system and presented as improvement, substantial improvement, or relief. Results Subjects in these studies reported statistically significant improvement, substantial improvement, and relief for vaginal dryness (p \u3c 0.00001), dyspareunia (p \u3c 0.001) and statistically significant improvement and relief for vaginal and/or vulvar irritation/itching (p \u3c 0.01) from baseline to week 12 with ospemifene compared with placebo. A similar trend was observed for women who reported substantial improvement of vaginal and/or vulvar irritation/itching. Conclusions For drug registration purposes, the use of the MBS model is appealing because of its simplicity and ease of scientific validation. However, the MBS model may underestimate the total magnitude of the clinical benefit of ospemifene treatment for symptomatic women suffering from VVA